Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 2, 2015
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
Fri, October 30, 2015
[ Fri, Oct 30th 2015
] - WOPRAI
[ Fri, Oct 30th 2015
] - WOPRAI
[ Fri, Oct 30th 2015
] - WOPRAI
[ Fri, Oct 30th 2015
] - WOPRAI
[ Fri, Oct 30th 2015
] - WOPRAI
[ Fri, Oct 30th 2015
] - WOPRAI
Andrew Fein Upgraded (VRTX) to Strong Buy and Increased Target to $155 on, Oct 30th, 2015
Andrew Fein of HC Wainwright & Co., Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Strong Buy and Increased Target from $85 to $155 on, Oct 30th, 2015.
Andrew has made no other calls on VRTX in the last 4 months.
There are 5 other peers that have a rating on VRTX. Out of the 5 peers that are also analyzing VRTX, 2 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Biren Amin of "Jefferies" Initiated at Hold and Held Target at $130 on, Wednesday, September 9th, 2015
- Ying Huang of "B of A Securities" Maintained at Hold with Increased Target to $133 on, Monday, July 6th, 2015
These are the ratings of the 3 analyists that currently disagree with Andrew
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $148 on, Friday, October 2nd, 2015
- Jasper Hellweg of "Argus Research" Upgraded from Hold to Strong Buy on, Monday, September 28th, 2015
- Liisa Bayko of "JMP Securities" Maintained at Buy with Increased Target to $148 on, Thursday, July 30th, 2015
